181 related articles for article (PubMed ID: 18397621)
1. [Prevalence and prognostic significance of pathological glucose metabolism in acute myocardial infarction].
Egstrup M; Henriksen FL; Høfsten DE; Hangaard J; Egstrup K
Ugeskr Laeger; 2008 Mar; 170(11):940-2. PubMed ID: 18397621
[TBL] [Abstract][Full Text] [Related]
2. Should oral glucose tolerance testing be mandatory following acute myocardial infarction?
Jessani S; Gangopadhyay K; Patel JV; Lip GY; Millane T
Int J Clin Pract; 2007 Apr; 61(4):680-3. PubMed ID: 17394440
[TBL] [Abstract][Full Text] [Related]
3. [Impaired glucose tolerance in patients with acute myocardial infarction].
Andersen GØ; Eritsland J; Aasheim A; Neuburger J; Knudsen EC; Mangschau A
Tidsskr Nor Laegeforen; 2006 Sep; 126(17):2264-7. PubMed ID: 16967066
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence of glucometabolic abnormalities in connection with myocardial infarction in a Danish coronary care unit].
Egstrup M; Henriksen FL; Høfsten DE; Jensen BK; Hangaard J; Egstrup K
Ugeskr Laeger; 2008 Mar; 170(11):942-6. PubMed ID: 18397622
[TBL] [Abstract][Full Text] [Related]
5. [Influence of impaired glucose tolerance on long-term survival after acute myocardial infarction].
Meier JJ; Deifuss S; Gallwitz B; Klamann A; Schmiegel W; Nauck MA
Dtsch Med Wochenschr; 2002 May; 127(21):1123-9. PubMed ID: 12085306
[TBL] [Abstract][Full Text] [Related]
6. Leptin: a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes.
Wallander M; Söderberg S; Norhammar A
Diabet Med; 2008 Aug; 25(8):949-55. PubMed ID: 18959608
[TBL] [Abstract][Full Text] [Related]
7. Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort.
Ritsinger V; Tanoglidi E; Malmberg K; Näsman P; Rydén L; Tenerz Å; Norhammar A
Diab Vasc Dis Res; 2015 Jan; 12(1):23-32. PubMed ID: 25311248
[TBL] [Abstract][Full Text] [Related]
8. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction.
Bartnik M; Malmberg K; Norhammar A; Tenerz A; Ohrvik J; Rydén L
Eur Heart J; 2004 Nov; 25(22):1990-7. PubMed ID: 15541834
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
[TBL] [Abstract][Full Text] [Related]
10. Oral glucose tolerance test: a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice: a report on repeated oral glucose tolerance tests from the GAMI study.
Wallander M; Malmberg K; Norhammar A; Rydén L; Tenerz A
Diabetes Care; 2008 Jan; 31(1):36-8. PubMed ID: 17909086
[TBL] [Abstract][Full Text] [Related]
11. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
[TBL] [Abstract][Full Text] [Related]
12. [Chronic miocardial infarction among patients with diabetes mellitus or impaired glucose tolerance].
Mihalcea C; Pandele GI
Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):685-91. PubMed ID: 20191816
[TBL] [Abstract][Full Text] [Related]
13. Should oral glucose tolerance test be a routine examination after a myocardial infarction?
Henareh L; Berglund M; Agewall S
Int J Cardiol; 2004 Oct; 97(1):21-4. PubMed ID: 15336801
[TBL] [Abstract][Full Text] [Related]
14. Diabetes, pre-diabetes and associated risks on Minnesota code-indicated major electrocardiogram abnormality among Chinese: a cross-sectional diabetic study in Fujian province, southeast China.
Lin L; Chen G; Zou X; Zhao J; Zhu F; Tu M; Xu S; Lin W; Yang S; Zhang Y; Lin M; Chen N; Huang H; Liang J; Li L; Yao J
Obes Rev; 2009 Jul; 10(4):420-30. PubMed ID: 19460110
[TBL] [Abstract][Full Text] [Related]
15. Poor reproducibility of the oral glucose tolerance test in the diagnosis of diabetes during percutaneous coronary intervention.
Jiménez-Navarro MF; Garcia-Pinilla JM; Garrido-Sanchez L; Alonso-Briales JH; Pérez-Cabeza A; Ortiz-García C; Hernández-Garcia JM; Tinahones F; de Teresa E
Int J Cardiol; 2010 Jul; 142(3):245-9. PubMed ID: 19232754
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre-diabetes and diabetes. The KORA Myocardial Infarction Registry.
Ziegler D; Rathmann W; Meisinger C; Dickhaus T; Mielck A;
Eur J Pain; 2009 Jul; 13(6):582-7. PubMed ID: 18782673
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study.
Mavrogiannaki A; Karamanos B; Manesis EK; Papatheodoridis GV; Koskinas J; Archimandritis AJ
J Viral Hepat; 2009 Jun; 16(6):430-6. PubMed ID: 19200136
[TBL] [Abstract][Full Text] [Related]
18. Temporal change in glucose tolerance in non-ST-elevation myocardial infarction.
Srinivas-Shankar U; Somauroo JD; Delduca AM; Jordan TS; Bowles SA; Rutter MK
Diabetes Res Clin Pract; 2008 Dec; 82(3):310-6. PubMed ID: 18842319
[TBL] [Abstract][Full Text] [Related]
19. Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum.
Karasik A
Ann Med; 2005; 37(4):250-8. PubMed ID: 16019723
[TBL] [Abstract][Full Text] [Related]
20. Reduced levels of anti-MDA LDL antibodies in patients with carbohydrate metabolism disorders.
Garrido-Sánchez L; García-Pinilla JM; Jiménez-Navarro M; Fernández-Pastora J; Alonso-Briales JH; Hernández-Garcia JM; De-Teresa-Galván E; Tinahones FJ
Clin Lab; 2011; 57(11-12):901-7. PubMed ID: 22239020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
